AzTrials
AzTrials

Periampullar DiseaseNCT05088564

Efficacy of Hemi-double-stapling Technique

A study testing Hand-sewn and Hemi-double stapling in people with Periampullar Disease, run by Gangnam Severance Hospital at 1 site in South Korea.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Surgical stapler is used in all areas of surgical operation. Surgical stapler has been used in various surgical fields for a long time, so its stability has already been proven. After gastrectomy or colectomy, the hemi-double stapling technique, which is an improved double stapling technique, has been applied as an… Read more about this study

Who is it for?
Ages 20 years and older
Conditions the study is for
Periampullar Disease
What is being tested?
Hand-sewn and Hemi-double stapling
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
180 participants
Where
1 siteSouth Korea
Study dates
23 Apr 2021to 22 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • pylorus-preserving pancreaticoduodenectomy
  • ECOG scale 0-1
  • Age > 19
  • Appropriate organ function as below i.WBC : ≥2500 mm3, ≤14000 mm3 ii.Hemoglobin : ≥9.0 g/dL iii.Platelet : ≥100,000 mm3 iv.Total bilirubin : ≤2.0 mg/dL (except for occlusive jaundice) v.Creatinine : ≤2.0 mg/dL
  • patient who can understand and sign the informed consent

Who cannot join

  • previous history of gastrectomy
  • ulcerative scar around ampulla of duodenum on endoscopy
  • previous history of upper abdomen surgery (open)
  • Emergency
  • Severe ischemic heart disease
  • Severe hepatic failure by liver cirrhosis or hepatitis
Show all 13Show fewer
  • Severe respiratory failure that requires oxygene inhalation
  • Chronic renal failure that requires hemodialysis
  • Expecting combine resection of other organ
  • Immunosuppressive therapy
  • Accompanying cancer with potential for adverse events
  • Severe psychologic or neurologic disease
  • drug or alcohol addiction

Trial locations and contacts

1 site in 1 country.

Joon Seoung Park contact

82-2-2019-2444

jspark330@yuhs.ac

South Korea1 site, 1 recruiting
  • Gangnam Severance Hospital

    Seoul

    JoonSeoung Park, 82-2-2019-2999, JSPARK330@yuhs.ac

    Recruiting

Other trials in South Korea

About this study

Official title: Pylorus-preserving Pancreaticoduodenectomy Using a Hemi-double-stapling Technique

Surgical stapler is used in all areas of surgical operation. Surgical stapler has been used in various surgical fields for a long time, so its stability has already been proven. After gastrectomy or colectomy, the hemi-double stapling technique, which is an improved double stapling technique, has been applied as an anastomosis method using a stapler.

In the duodenojejunal anastomosis after PPPD, the hemi-double stapling method can be applied to preserve the pyloric branch of the vagus nerve and the branch of the right gastric artery to ensure sufficient blood supply. Ultimately, it is expected to shorten the anastomosis time as well as reduce the frequency of delayed gastric emptying. In addition, the work of physically expanding the pylorus to insert the circular anastomosis is also thought to reduce gastric emptying delay.

Read the detailed description

(1) Stapling technique

  1. Make purse-string suture on jejunum at the point of duodenojejunostomy
  2. Insert Anvil into jejunem
  3. Make incision of 3-4 centimeters at anterior side of antrum
  4. Long Kelly forceps are inserted into the stomach to dilate the pylorus
  5. A 25 mm end-to-end anastomosis (EEA) stapler is inserted into the stomach and passed through the pylorus.
  6. The needle of EEA stapler is pierced through the lower part of the stapler line where the duodenum has been resected
  7. The EEA stapler is combined with the anvil and anastomosis is performed
  8. The incision on the stomach is sutured through a linear stapler
  9. Reinforcement suture for stapler line (2) Postoperative management
  • Diet build up as same manner of hand-sewn group (3) Postoperative follow-up
  • All postoperative complication, delayed gastric emptying, intraperitoneal abscess, postoperative pancreatic fistula, postpancreatectomy hemorrhage, hospital stay, reoperation, readmission and 2-months mortality.
Being tested
Hand-sewn, Hemi-double stapling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hand-sewnProcedure or surgery

    Doudenojejunal anastomosis by hand-sewn method

  • Hemi-double staplingProcedure or surgery

    Doudenojejunal anastomosis by hemi-double-stapling method "EEA25 - Covidien EEA Circular Stapler DST Series 25.0mm x 4.8mm" is used for anastomosis

Study groups in NCT05088564
Study groupRoleWhat they receive
I (Hand-sewn group)ExperimentalDoudenojejunal anastomosis by hand-swen method
Receives: Procedure: Hand-sewn
II (Stapling group)Active comparatorDoudenojejunal anastomosis by hemi-double-stapling method
Receives: Procedure: Hemi-double stapling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Grade of delayed gastric emptying by ISGPS

    Delayed gastric emptying will be evaluated at postoperative 21 day using International study group of pancreatic surgery (ISGPS) classification. According to ISGPS classification, delayed gastric emptying is divided into three grades from A to C. Grade C means worse than grade A.-->Unit of Measure: Grade A,B,C

    Measured: At postoperative 21 day

Secondary outcomes (1)
  1. hospital stay

    Duration (days) of hospital stay, which means interval between operation day and discharge day will be checked up to postoperative 2 months. --> Unit of Measure: days

    Measured: At postoperative 21 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start23 Apr 2021
  3. Primary completion22 Apr 2024 (estimated)
  4. Study completion22 Apr 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
180 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05088564
Sponsor's protocol ID
3-2021-0084
Status last verified
Oct 2022
First submitted
8 Aug 2021
Last updated
25 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Hand-sewn and Hemi-double stapling in people with Periampullar Disease, run by Gangnam Severance Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Joon Seoung Park (82-2-2019-2444, jspark330@yuhs.ac), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Grade of delayed gastric emptying by ISGPS (time frame: At postoperative 21 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Oct 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in